Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Recognition of mechanisms involved in bile resistance important to halting antimicrobial resistance in nontyphoidal Salmonella.

Tsai MH, Wu SR, Lee HY, Chen CL, Lin TY, Huang YC, Chiu CH.

Int J Antimicrob Agents. 2012 Aug;40(2):151-7. doi: 10.1016/j.ijantimicag.2012.04.016. Epub 2012 Jun 27.

PMID:
22743016
[PubMed - indexed for MEDLINE]
2.

Contribution of different mechanisms to the resistance to fluoroquinolones in clinical isolates of Salmonella enterica.

Rushdy AA, Mabrouk MI, Abu-Sef FA, Kheiralla ZH, Mohamed Abdel-All S, Saleh NM.

Braz J Infect Dis. 2013 Jul-Aug;17(4):431-7. doi: 10.1016/j.bjid.2012.11.012. Epub 2013 Jun 3.

PMID:
23742803
[PubMed - indexed for MEDLINE]
Free Article
3.

Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.

Kehrenberg C, de Jong A, Friederichs S, Cloeckaert A, Schwarz S.

J Antimicrob Chemother. 2007 May;59(5):886-92. Epub 2007 Mar 16. Erratum in: J Antimicrob Chemother. 2007 Nov;60(5):1181-2.

PMID:
17369276
[PubMed - indexed for MEDLINE]
Free Article
4.

Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates.

Lunn AD, Fàbrega A, Sánchez-Céspedes J, Vila J.

Int Microbiol. 2010 Mar;13(1):15-20.

PMID:
20890836
[PubMed - indexed for MEDLINE]
5.

The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.

Turner AK, Nair S, Wain J.

J Antimicrob Chemother. 2006 Oct;58(4):733-40. Epub 2006 Aug 8.

PMID:
16895934
[PubMed - indexed for MEDLINE]
Free Article
6.

Resistance to fluoroquinolones linked to gyrA and par C mutations and overexpression of acr AB efflux pump in Salmonella enterica serotype Choleraesuis.

Chu C, Su LH, Chu CH, Baucheron S, Cloeckaert A, Chiu CH.

Microb Drug Resist. 2005 Fall;11(3):248-53.

PMID:
16201927
[PubMed - indexed for MEDLINE]
7.

Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.

Jeong HS, Kim JA, Shin JH, Chang CL, Jeong J, Cho JH, Kim MN, Kim S, Kim YR, Lee CH, Lee K, Lee MA, Lee WG, Shin JH, Lee JN.

Microb Drug Resist. 2011 Dec;17(4):551-7. doi: 10.1089/mdr.2011.0095. Epub 2011 Aug 10.

PMID:
21830947
[PubMed - indexed for MEDLINE]
8.

Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.

Montanari MP, Tili E, Cochetti I, Mingoia M, Manzin A, Varaldo PE.

Microb Drug Resist. 2004 Fall;10(3):209-17.

PMID:
15383164
[PubMed - indexed for MEDLINE]
9.

[Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].

Guo Y, Pei X, Liu X.

Wei Sheng Yan Jiu. 2004 Sep;33(5):591-4. Chinese.

PMID:
15612489
[PubMed - indexed for MEDLINE]
10.

Insertion sequence disruption of adeR and ciprofloxacin resistance caused by efflux pumps and gyrA and parC mutations in Acinetobacter baumannii.

Lopes BS, Amyes SG.

Int J Antimicrob Agents. 2013 Feb;41(2):117-21. doi: 10.1016/j.ijantimicag.2012.08.012. Epub 2012 Dec 3.

PMID:
23217848
[PubMed - indexed for MEDLINE]
11.

[Resistance to quinolones and beta-lactams in Salmonella enterica due to mutations in topoisomerase-encoding genes, altered cell permeability and expression of an active efflux system].

Miró E, Vergés C, García I, Mirelis B, Navarro F, Coll P, Prats G, Martínez-Martínez L.

Enferm Infecc Microbiol Clin. 2004 Apr;22(4):204-11. Spanish.

PMID:
15056435
[PubMed - indexed for MEDLINE]
12.

Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms.

Cebrián L, Rodríguez JC, Escribano I, Royo G.

Chemotherapy. 2005 Mar;51(1):40-3. Epub 2005 Mar 14.

PMID:
15767744
[PubMed - indexed for MEDLINE]
13.

Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.

Saito R, Sato K, Kumita W, Inami N, Nishiyama H, Okamura N, Moriya K, Koike K.

J Antimicrob Chemother. 2006 Sep;58(3):673-7. Epub 2006 Jul 26.

PMID:
16870650
[PubMed - indexed for MEDLINE]
Free Article
14.

Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.

Gaind R, Paglietti B, Murgia M, Dawar R, Uzzau S, Cappuccinelli P, Deb M, Aggarwal P, Rubino S.

J Antimicrob Chemother. 2006 Dec;58(6):1139-44. Epub 2006 Oct 28.

PMID:
17071955
[PubMed - indexed for MEDLINE]
Free Article
15.

Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.

Zheng J, Cui S, Meng J.

J Antimicrob Chemother. 2009 Jan;63(1):95-102. doi: 10.1093/jac/dkn448. Epub 2008 Nov 4.

PMID:
18984645
[PubMed - indexed for MEDLINE]
Free Article
16.

Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.

Malhotra-Kumar S, Van Heirstraeten L, Lammens C, Chapelle S, Goossens H.

J Antimicrob Chemother. 2009 May;63(5):886-94. doi: 10.1093/jac/dkp057. Epub 2009 Mar 11.

PMID:
19279051
[PubMed - indexed for MEDLINE]
Free Article
17.

The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).

Preisler A, Heisig P.

J Antimicrob Chemother. 2009 Feb;63(2):290-4. doi: 10.1093/jac/dkn480. Epub 2008 Nov 24.

PMID:
19033246
[PubMed - indexed for MEDLINE]
Free Article
18.

[Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].

Lei YC, Wang HB, Sun ZY, Shen ZY.

Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):403-7. Chinese.

PMID:
12820918
[PubMed - indexed for MEDLINE]
19.

Characterization of the quinolone resistance mechanism in foodborne Salmonella isolates with high nalidixic acid resistance.

Kim KY, Park JH, Kwak HS, Woo GJ.

Int J Food Microbiol. 2011 Mar 15;146(1):52-6. doi: 10.1016/j.ijfoodmicro.2011.01.037. Epub 2011 Feb 2.

PMID:
21354645
[PubMed - indexed for MEDLINE]
20.

Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.

Hassing RJ, Menezes GA, van Pelt W, Petit PL, van Genderen PJ, Goessens WH.

Int J Antimicrob Agents. 2011 Mar;37(3):240-3. doi: 10.1016/j.ijantimicag.2010.10.026. Epub 2011 Jan 11.

PMID:
21227657
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk